Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the participation of its…
The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of$0.36 per share.
The safety profile of KEYTRUDA was consistent with thatpreviously observed in gastric cancer
Teva recalls 35 lots of bulk LosartanPotassium USP Tablets.
Celgene posts strong double-digit top- and bottom-line growth across portfolioand geographies
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m.…
-ADCETRIS® (Brentuximab Vedotin) Net Sales in U.S. and Canada Were $135.0 Million in the First Quarter, an Increase of 42…
DUBLIN–(BUSINESS WIRE)–The “Drug Addiction – Pipeline Review, H1 2019” report has been added to ResearchAndMarkets.com’s offering. Drug Addiction – Pipeline…
DUBLIN–(BUSINESS WIRE)–The “Multiple Myeloma: Epidemiology Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. In 2017, the 8MM had…
DUBLIN–(BUSINESS WIRE)–The “Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026” report has been added to ResearchAndMarkets.com’s offering. “Idiopathic Pulmonary Fibrosis: Competitive…